PDF(1097 KB)
肺炎支原体肺炎患儿肺炎支原体耐药性与DNA载量和基因型的关系研究
张慧芬, 白海涛, 李基明, 谢辉, 王烨
中国当代儿科杂志 ›› 2017, Vol. 19 ›› Issue (11) : 1180-1184.
PDF(1097 KB)
PDF(1097 KB)
肺炎支原体肺炎患儿肺炎支原体耐药性与DNA载量和基因型的关系研究
Association of drug resistance of Mycoplasma pneumoniae with DNA load and genotypes in children with Mycoplasma pneumoniae pneumonia
目的 探讨肺炎支原体（MP）肺炎患儿MP耐药情况及其与DNA载量和基因型的关系。方法 选取2012年1月至2016年12月诊断为MP肺炎的230例住院患儿为研究对象，采集所有患儿咽拭子标本，采用快速培养基培养药敏法测定9种常用抗菌药物对MP临床分离株的药物敏感性；荧光实时定量PCR检测患儿咽拭子MP-DNA载量；PCR测序检测MP 23S rRNA V区2063位基因型。结果 230例MP患儿中，86例2063位基因型为A（37.4%），134例为G（58.3%），8例为C（3.5%），2例为T（0.9%）。突变基因型（G+C+T）MP-DNA载量高于野生基因型（A）菌株（P < 0.05）；红霉素、阿奇霉素、克拉霉素、克林霉素耐药组MP-DNA载量高于非耐药组（P < 0.05）。MP对大环内酯类抗生素耐药率较高，60%以上产生大环内酯类耐药的病例均检测出A2063G突变，喹诺酮类药物少见MP耐药（低于2%）。结论 23S rRNA V区2063位点发生基因突变可能导致MP对大环内酯类药物耐药和DNA载量的变化，可作为MP治疗用药的选择依据。
Objective To investigate the association of drug resistance of Mycoplasma pneumoniae (MP) with DNA load and genotypes in children with MP pneumonia. Methods A total of 230 children who were hospitalized and diagnosed with MP pneumonia between January 2012 and December 2016 were enrolled. Throat swabs were collected from the 230 children, and a rapid drug sensitivity assay was used to determine the sensitivity of clinical isolates of MP to nine commonly used antibacterial agents. Quantitative real-time PCR was used to measure MP-DNA load in throat swabs. PCR sequencing was used to determine the genotype of 2063 locus of the MP 23S rRNA V domain. Results Of the 230 children, 86 (37.4%) had genotype A in 2063 locus, 134 (58.3%) had genotype G, 8 (3.5%) had genotype C, and 2 (0.9%) had genotype T. Mutant strains (genotype G+C+T) had a significantly higher MP-DNA load than wild-type strains (genotype A) (P < 0.05). The strains resistant to erythromycin, azithromycin, clarithromycin, and clindamycin had a significantly higher MP-DNA load than non-resistant strains (P < 0.05). MP had a high drug resistance rate to macrolide antibiotics. More than 60% of the cases with resistance to macrolides were found to have A2063G mutations. MP was rarely resistant to quinolones (less than 2%). Conclusions Mutations in 2063 locus of the MP 23S rRNA V domain may result in the resistance of MP to macrolides and the change in DNA load and can be used as a basis for selecting drugs for MP.
[1] 辛德莉, 史大伟. 耐药肺炎支原体感染的抗生素治疗进展[J]. 中华实用儿科临床杂志, 2013, 28(22):1695-1697.
[2] 郑杨, 崔红. 肺炎支原体耐药机制的研究现状[J].中国医刊, 2009, 44(12):18-20.
[3] 辛德莉,韩旭,糜祖煌, 等. 肺炎支原体对大环内酯类抗生素耐药性及耐药机制研究[J].中华检验医学杂志, 2008, 31(5):543-546.
[4] 冯真英,叶少玲,陈文兴, 等. 肺炎支原体对大环内酯类抗生素耐药性及耐药机制研究[J].中国现代药物应用, 2016, 10(13):137-139.
[5] 孔洁,陈友国,管敏昌,等. 肺炎支原体23S rRNA耐药基因2063位点阳性的肺炎支原体肺炎患儿临床特征及BALF中IL-8表达[J].中国卫生检验杂志, 2016, 26(23):3385-3388
[6] 中华人民共和国国家卫生和计划生育委员会. 卫生部办公厅关于印发小儿内科4个病种临床路径的通知[DB/OL]. (2009-10-16)[2017-03-20]. http://www.nhfpc.gov.cn/yzygj/s3585u/200910/81422313e01b45fd90a2f633d748e946.shtml.
[7] 张瑾, 胡大康. 肺炎支原体载量指数在儿童肺炎支原体感染诊断中的应用[J]. 中华医院感染学杂志, 2009, 19(12):1613-1615.
[8] Lucier TS, Heitzman K, Liu SK, et al. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae[J]. Antimicrob Agents Chemother, 1995, 39(12):2770-2773.
[9] Xin D, Mi Z, Han X, et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China[J]. Antimicrob Agents Chemother, 2009, 53(5):2158-2159.
[10] Zhao F, Liu G, Wu J, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012[J]. Antimicrob Agents Chemother, 2013, 57(3):1521-1523.
[11] Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China[J]. Clin lnfect Dis, 2010, 51(2):189-194.
[12] Wang Y, Qiu S, Yang G, et al. An outbreak of Mycoplasma pneumoniae caused by a macrolide-resistant isolate in a nursery school in China[J]. Antimicrob Agents Chemother, 2012, 56(7):3748-3752.
[13] Pereyre S, Guyot C, Renaudin H, et al. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae[J]. Antimicrob Agents Chemother, 2004, 48(2):460-465.
[14] Diaz MH, Benitez AJ, Cross KE, et al. Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States[J]. Open Forum Infect Dis, 2015, 2(3):ofv106.
[15] Yan C, Sun H, Xue G, et al. A single-tube multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens by use of multiplex PCR-capillary electrophoresis[J]. J Clin Microbiol, 2014, 52(12):4168-4171.
[16] Xue G, Wang Q, Yan C, et al. Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China[J]. J Clin Microbiol, 2014, 52(5):1478-1482.
[17] Qu J, Yu X, Liu Y, et al. Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility[J]. PLoS One, 2013, 8(12):e82174.
[18] Tian XJ, Dong YQ, Dong XP, et al. P1 gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2010 and relationship between genotyping and macrolide resistance[J]. Chin Med J (Engl), 2013, 126(20):3944-3948.
[19] Aldred KJ, Kerns RJ, Osheroff N, et al. Mechanism of quinolone action and resistance[J]. Biochemistry, 2014, 53(10):1565-1574.
厦门市科技局计划项目（3502Z20144048）。
